Jamison Private Wealth Management Inc. Has $2.37 Million Stock Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Jamison Private Wealth Management Inc. lifted its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 16.1% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 4,539 shares of the medical equipment provider’s stock after purchasing an additional 631 shares during the quarter. Jamison Private Wealth Management Inc.’s holdings in Intuitive Surgical were worth $2,369,000 as of its most recent SEC filing.

Other hedge funds also recently modified their holdings of the company. Blue Square Asset Management LLC raised its position in Intuitive Surgical by 2.4% during the fourth quarter. Blue Square Asset Management LLC now owns 10,991 shares of the medical equipment provider’s stock valued at $5,737,000 after purchasing an additional 259 shares in the last quarter. TTP Investments Inc. acquired a new stake in Intuitive Surgical during the 4th quarter worth approximately $207,000. AlphaMark Advisors LLC increased its holdings in Intuitive Surgical by 300.0% in the fourth quarter. AlphaMark Advisors LLC now owns 96 shares of the medical equipment provider’s stock valued at $50,000 after purchasing an additional 72 shares during the period. Jacksonville Wealth Management LLC acquired a new stake in shares of Intuitive Surgical in the fourth quarter valued at about $2,108,000. Finally, Flagship Harbor Advisors LLC increased its position in Intuitive Surgical by 3.2% during the 4th quarter. Flagship Harbor Advisors LLC now owns 3,165 shares of the medical equipment provider’s stock valued at $1,652,000 after purchasing an additional 97 shares during the period. Institutional investors own 83.64% of the company’s stock.

Insider Buying and Selling

In other Intuitive Surgical news, EVP Robert Desantis sold 376 shares of the company’s stock in a transaction dated Friday, November 29th. The stock was sold at an average price of $539.00, for a total value of $202,664.00. Following the transaction, the executive vice president now directly owns 5,506 shares in the company, valued at $2,967,734. This represents a 6.39 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CFO Jamie Samath sold 108 shares of the company’s stock in a transaction that occurred on Tuesday, November 26th. The stock was sold at an average price of $542.06, for a total transaction of $58,542.48. Following the completion of the transaction, the chief financial officer now owns 8,757 shares in the company, valued at approximately $4,746,819.42. This trade represents a 1.22 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders have sold 42,475 shares of company stock valued at $22,070,807. Corporate insiders own 0.90% of the company’s stock.

Intuitive Surgical Price Performance

NASDAQ:ISRG opened at $584.05 on Friday. Intuitive Surgical, Inc. has a 1 year low of $364.17 and a 1 year high of $616.00. The stock’s fifty day moving average price is $547.16 and its two-hundred day moving average price is $504.35. The company has a market cap of $208.03 billion, a P/E ratio of 93.90, a P/E/G ratio of 5.19 and a beta of 1.39.

Analyst Upgrades and Downgrades

Several research firms have recently weighed in on ISRG. JPMorgan Chase & Co. lifted their price objective on Intuitive Surgical from $575.00 to $675.00 and gave the stock an “overweight” rating in a research report on Friday. Leerink Partners lifted their price objective on shares of Intuitive Surgical from $489.00 to $502.00 in a report on Thursday, October 17th. Royal Bank of Canada increased their price target on Intuitive Surgical from $525.00 to $555.00 and gave the company an “outperform” rating in a research report on Friday, October 18th. Erste Group Bank upgraded shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a research note on Tuesday, November 19th. Finally, Wells Fargo & Company raised their price target on shares of Intuitive Surgical from $630.00 to $687.00 and gave the company an “overweight” rating in a research report on Friday. One analyst has rated the stock with a sell rating, three have assigned a hold rating and fifteen have given a buy rating to the company. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $583.83.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.